AU2003281325A1 - Secreted and cytoplasmic tumor endothelial markers - Google Patents

Secreted and cytoplasmic tumor endothelial markers

Info

Publication number
AU2003281325A1
AU2003281325A1 AU2003281325A AU2003281325A AU2003281325A1 AU 2003281325 A1 AU2003281325 A1 AU 2003281325A1 AU 2003281325 A AU2003281325 A AU 2003281325A AU 2003281325 A AU2003281325 A AU 2003281325A AU 2003281325 A1 AU2003281325 A1 AU 2003281325A1
Authority
AU
Australia
Prior art keywords
secreted
tumor endothelial
endothelial markers
cytoplasmic
cytoplasmic tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003281325A
Other versions
AU2003281325A8 (en
Inventor
Kenneth W. Kinzler
Brad St. Croix
Bert Vogelstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU2003281325A1 publication Critical patent/AU2003281325A1/en
Publication of AU2003281325A8 publication Critical patent/AU2003281325A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2003281325A 2002-07-02 2003-07-02 Secreted and cytoplasmic tumor endothelial markers Abandoned AU2003281325A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39302302P 2002-07-02 2002-07-02
US60/393,023 2002-07-02
US45896403P 2003-04-01 2003-04-01
US60/458,964 2003-04-01
PCT/US2003/016250 WO2004005883A2 (en) 2002-07-02 2003-07-02 Secreted and cytoplasmic tumor endothelial markers

Publications (2)

Publication Number Publication Date
AU2003281325A1 true AU2003281325A1 (en) 2004-01-23
AU2003281325A8 AU2003281325A8 (en) 2004-01-23

Family

ID=30118367

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003281325A Abandoned AU2003281325A1 (en) 2002-07-02 2003-07-02 Secreted and cytoplasmic tumor endothelial markers

Country Status (2)

Country Link
AU (1) AU2003281325A1 (en)
WO (1) WO2004005883A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2561887B8 (en) 2003-01-14 2016-12-21 Dana-Farber Cancer Institute, Inc. Cancer therapy sensitizer
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US8420603B2 (en) 2004-05-14 2013-04-16 Abraxis Bioscience, Llc SPARC and methods of use thereof
AU2006249235B2 (en) 2004-05-14 2010-11-11 Abraxis Bioscience, Llc Sparc and methods of use thereof
EP1813943B1 (en) * 2004-10-19 2009-09-23 Kumamoto University Novel diagnostic kit for malignant melanoma
JP2008535475A (en) 2005-02-18 2008-09-04 アブラクシス バイオサイエンス、インコーポレイテッド Q3SPARC deletion mutant and use thereof
AU2007317753B2 (en) 2006-11-09 2013-11-07 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Differential gene expression in physiological and pathological angiogenesis
WO2008101118A2 (en) 2007-02-14 2008-08-21 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services A gene expression signature identifying pro-angiogenic genes in ovarian tumor endothelial cell isolates
JP5685773B2 (en) * 2007-09-07 2015-03-18 ミート アンド ライブストック オーストラリア リミテッド Drugs with angiogenic and wound healing activity
JP5960946B2 (en) * 2008-10-27 2016-08-02 北海道公立大学法人 札幌医科大学 Cancer stem cell molecular marker
CN101708328A (en) * 2009-11-06 2010-05-19 上海市免疫学研究所 Pharmaceutical application of CYR61 protein
EP2715348B1 (en) * 2011-06-02 2019-04-10 Almac Diagnostic Services Limited Molecular diagnostic test for cancer
WO2014087156A1 (en) 2012-12-03 2014-06-12 Almac Diagnostics Limited Molecular diagnostic test for cancer
KR101535717B1 (en) * 2013-09-11 2015-07-09 연세대학교 산학협력단 Composition for pancreatic cancer diagnosis comprising complememt factor i-specific binding polypeptide or antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1307557A2 (en) * 2000-08-02 2003-05-07 The Johns Hopkins University Endothelial cell expression patterns

Also Published As

Publication number Publication date
WO2004005883A3 (en) 2006-07-27
AU2003281325A8 (en) 2004-01-23
WO2004005883A2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2003240252A1 (en) Planar antenna and antenna system
AU2003284222A1 (en) Bioabsorbable marker having external anchoring means
AU2003235470A1 (en) Predictive markers in cancer therapy
AU2003297421A1 (en) Advertising mat
AU2003244417A1 (en) Cellular mosfet devices and their manufacture
AU2003281287A1 (en) Toxicity markers
EP1581792A4 (en) Multi-functional product markers and methods for making and using the same
AU2003268508A1 (en) Emissive highway markers
AU2002238814A1 (en) Provision of location information
AU2003281325A1 (en) Secreted and cytoplasmic tumor endothelial markers
AU2003295355A1 (en) Anchor
AU2003214438A1 (en) Providing location dependent information
AU2003286973A1 (en) Moxa-cautery equipment and additional equipment
GB0225360D0 (en) Genetic markers
AU2003211112A1 (en) Secreted proteins
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003251356A1 (en) Viral marker
AU2003222189A1 (en) Secreted proteins
AU2003245092A1 (en) Sound-absorbing material
AU2003215379A1 (en) Substituted pyrimidinones and pyrimidinthiones
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003240603A1 (en) Examination and demonetization system for value markers
AU2003218924A1 (en) Luminescent markers
AU2003300859A1 (en) Carrier-ligand fusions and uses thereof
AU2003248933A1 (en) Secreted proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase